In contrast, a recent Mendelian randomization study that included a European population reported that higher levels of genetically predicted bioavailable serum testosterone in men were associated with an increased risk of both CKD and albuminuria and with lower eGFR based on creatinine or a combination of creatinine and cystatin C (52). The gene discussed is CST3; the disease is chronic kidney disease.